Find an expert

Dr Walweel is an electrophysiologist specializing in calcium-released channels (RyR2) regulation in heart. Walweel's research project is to understand how RyR2 regulates heart contraction and rhythm, how their dysregulation leads to cardiac arrhythmias, and how pharmacological interventions targeting RyR2 restore normal heart rhythm. She is expert in bilayer work, single channel recording and biochemistry. Walweel's discoveries are clinically important for understanding arrhythmia generation in patients with heart failure and CPVT. Dr Walweel works with the purpose to promote human heart research and health. She aims to reduce heart failure burden and death by advancing pathophysiological research and discovering suitable medication to prevent arrhythmias. Over a relatively short time, Dr Walweel's research resulted in notable and meritorious publications in high quality journals (JACC, Circ Res, Mol Pharmacol, J Gen Physiol, J Mol Cell Cardiol and J Biomed Sciences).

Dr Haolu Wang currently is a Medical Registrar and Basic Physician Trainee with the Royal Australasian College of Physicians - The Prince Charles Hospital and Redcliffe Hospital (Northside) Rotation. He is also an Honorary Research Fellow in the joint liver cancer research program of Frazer Institute, The University of Queensland and Gallipoli Medical Research Foundation. Dr Wang received his Bachelor of Medicine and Master of Surgery qualifications from Shanghai Jiao Tong University School of Medicine. He was awarded his PhD in Clinical Medicine from The University of Queensland. Dr Wang has worked as a Medical Officer at Renji Hospital, Shanghai Jiao Tong University School of Medicine and as a Researcher Officer at Frazer Institute, The University of Queensland.

Dr Wang has authored over 30 publications of clinical and translational research in liver diseases, including Hepatology, Theranostics, Int J Cancer, J Exp Clin Cancer Res and Pharmacol Ther. His standing in this field is reflected by awards from Australian National Health and Medical Research Council, United European Gastroenterology, European Microscopy Congress, The University of Queensland, Frazer Family Foundation and Shanghai Jiao Tong University.

Dr Sen Wang is an ARC DECRA Senior Research Fellow and Senior Lecturer in computer science and data science at the School of Information Technology and Electrical Engineering at UQ. He is also a CI on several health data analytics research grants. Sen has an interest in ICU data and has clinical collaborations with RBWH and Children’s Hospital. Dr Wang received his PhD degree in 2014 and his research interest includes various topics on Feature Selection, Semi-supervised Learning, Deep Learning, Pattern Recognition, Data Mining, and Health Informatics. Since 2010, Dr Wang has published 80+ academic papers in top conferences and journals. Most were published in internationally renowned journals and conferences in the fields of data science, data mining, and machine learning, such as Algorithmica, TNNLS, TMC, TKDE, TCYB, TMM, WWWJ, Signal Processing, ACM TOMM, ACM MM, IJCAI, AAAI, SDM, CIKM, CVPR, ICCV, ICDM, ISWC, ECML-PKDD, PAKDD, ICONIP, ICPADS, and WISE, all CORE A/A* journals and conferences.

Dr. Geng Wang is a postdoctoral research fellow specializing in statistical genetics and genetic epidemiology at the Institute for Molecular Bioscience, University of Queensland. His research focuses on the developmental origins of health and diseases, causal inference in genetic epidemiology, genetic susceptibility of complex traits and diseases, and the advancement of statistical genetics methodologies. Proficient in bioinformatics, statistical genetics, and clinical research, he has a background in clinical medicine and the biotechnology industry.

Dr. Wang obtained his bachelor's degree in clinical medicine and master's degree in internal medicine from Second Military Medical University (Shanghai, China) in 2012 and 2016, respectively. He served as a resident physician at Changzheng Hospital, affiliated with Second Military Medical University, from 2016 to 2017, specialising in rheumatology, before being promoted to an attending doctor. During his time in Shanghai, he was invited to visit the Translational Research Institute (Australia) twice in 2016 and 2017 for bioinformatics training and collaborative research.

Driven by his growing interest in human genetics, Dr. Wang pursued a Ph.D. in statistical genetics with Professor David Evans at the University of Queensland, which he successfully completed in 2023. Since then, he has continued his research in the aforementioned areas, contributing to the field with his diverse background and expertise.

Eva (Xiaoyi) completed her PhD in Viticulture and Horticulture from Adelaide University. Before starting her career at UQ, she did an industry-focused and collaborative research project at Adelaide University, working with the University of Melbourne, the University of Tasmania and NSW DPI on drought management in grapevine, orange and almond across the four Australian states.

Eva's research expertise includes plant physiology, particularly in grapevines, with a strong emphasis on advanced techniques such as micro-CT and image analysis for characterizing plant structures. Her work also includes studies on vine balance, canopy microclimate, early yield prediction, and canopy management. She also has significant experience in RNA-seq and data analysis.

Currently, Eva is engaged in projects that assess the performance of wine grape varietals in Queensland's wine regions, as well as exploring the use of hydroponic and aeroponic systems for the production of grapes and other crops.

Honours and Masters projects are available in all active projects. Please register your interest emailing xiaoyi.wang1@uq.edu.au.

MBBS MM (Sydney), PhD (Cambridge), FRACP, FCSANZ, FRCP (London)

Consultant Cardiologist, Princess Alexandra Hospital, Brisbane.

Associate Professor, PAH-Southside Clinical Unit, Faculty of Medicine, The University of Queensland.

Research interests: clinical cardiology, cardiovascular imaging, genetics and indigenous health.

C.M. Wang joined the School of Civil Engineering, University of Queensland (UQ) in January 2017 as the Transport and Main Roads (TMR) Chair Professor of Structural Engineering. He graduated from Monash University in Civil Engineering with a First Class Honours in 1978 and was awarded M.Eng.Sc. and Ph.D. degrees from the same university in 1980 and 1982, respectively. Prior to joining UQ, Professor Wang held the positions as the Director for the Engineering Science Programme and the Director for the Global Engineering Programme, at the Faculty of Engineering of the National University of Singapore. Additionally, he was the Vice-Dean of Undergraduate Programmes of NUS Faculty of Engineering and the Associate Director of the Centre for Development in Teaching and Learning, NUS. He is also the Adjunct Professor in the Department of Civil Engineering, Monash University, Australia and was elected as Monash Civil Engineering Alumnus of the Year 2015 for his significant contributions to the engineering profession.

Professor Wang is a Chartered Structural Engineer, Fellow of Australian Academy of Technology and Engineering, Member of European Academy of Sciences and Arts, Fellow of Academy of Engineering Singapore, Fellow of Institution of Engineers Singapore, Fellow of Institution of Structural Engineers and Fellow of Society of Floating Solutions (Singapore). He was the Chairman of the IStructE Singapore Regional Group and the IStructE Council Member for 12 years. He was awarded 2009 Lewis Kent Award, 2014 Keith Eaton Award and IES Outstanding Volunteer Awards 2011 and 2008 for his outstanding leadership and significant contributions to IStructE and IES. Currently, he is Chairman of International Steering Committee of EASEC, Vice President of Society of Floating Solutions Singapore, member of International Advisory Committee of RILS and Senior Fellow of PolyU Academy for Interdisciplinary Research, Hong Kong PolyU. He is founding member of International Engineering Science Consortium that comprises 9 premier universities (UC Berkeley, Cornell Univ, Univ of Toronto, Osaka University, KTH Sweden, UCL, NUS, UQ, Auckland Univ).

Professor Wang is a highly sought after keynote speaker in international conferences. He has given over 50 keynote presentations and many seminars on very large floating structures, structural modeling and analysis in many countries. He has won a number of research awards such as 2019 Nishino Medal, 2019 JN Reddy Medal and best paper awards. He has provided consulting services and served as an expert in structures and very large floating structures to many public and private organizations, including JTC Corporation, Maritime and Port Authority of Singapore, Housing Development Board, Defence Science and Technology Agency, Jurong Consultants, Surbana International and Singapore Cruise Centre.

Dr Ran Wang graduated with her PhD in 2015, and after undertaking a postdoc position in Scripps Research, USA returned to Australia in 2017. She is now a Senior Postdoctoral Researcher supported by the prestigious Bushell Postdoctoral Research Fellowship from the Gastroenterology Society of Australia. Dr Wang is interested to understand the nature of inflammation in gut and lung and investigate the local and systemic impacts of chronic gut inflammation. In addition to a growing track-record in the mucosal immunology field, she is also building an inter-disciplinary research profile in material science and nanotechnology for drug delivery and immune modulation. She is the Associate Editor of Frontier of Cellular and Infection Microbiology Journal since 2018.

I lead the Technology-Driven Drug Discovery (Tech3D) Group at the Institute for Molecular Bioscience, UQ. We believe that the key to solving some of our world's biggest challenges, whether that be in medicine or agriculture, relies on the ability to precision engineer molecules at will. My group harnesses three technological pillars to engineer peptides and proteins, which are computational biology, molecular libraries, and nanotechnology. We aspire to design better drugs, creating next generation biotechnological agents that have real impact. These could be new cancer drugs that harness the body's immune system or new insecticides that are environmentally friendly. In these pursuits, we value advancement, fun, balance, respect, fairness, and integrity.

I have been involved in peptide and protein research for over two decades, and am highly experienced in bioinformatics, chemistry, structural characterization, biophysics, and biochemistry. I trained with experts in peptide and protein characterization: an Honours project with Professor Garry King at the University of New South Wales, Sydney, Australia (2004), an APA scholarship with Professor David Craik at the University of Queensland Institute for Molecular Bioscience, Brisbane, Australia (2005-2009) and a NHMRC fellowship with Professor Mingjie Zhang at the Hong Kong University of Science and Technology, Hong Kong, China (2009-2011) and A/Professor Andreas Hofmann at Griffith University Eskitis Institute, Brisbane, Australia (2011-2012). I returned to the University of Queensland in 2012 to join an industry partnership funded by an ARC linkage grant. I currently hold an ARC Future Fellowship and am responsible for a team of research officers, assistants and postgraduate students.

My research output has been recognised by >30 prizes and awards for leadership, research translation and fundamental research excellence, as well as numerous invitations to speak at academic and pharmaceutical conferences. I have over 100 publications and have been cited by researchers from across the world.